THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle

Stock Information for GT Biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About GT Biopharma Inc.

Ventripoint Issues Shares for Debt Settlement and Awards Option Grants
Ventripoint Announces Closing of Non-Brokered Units Private Placement
AI Diagnostics: The End of the High-Cost Imaging Era
Ventripoint Issues Shares for Payment of Debenture Interest
Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand
Ventripoint Announces Non-Brokered Units Private Placement
Ventripoint Diagnostics Announces Collaboration with Summit Sciences
Ventripoint to Issue Shares for Payment of Debenture Interest

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.